Daily Bulletin

US FDA Awards Fast Track Designation (FTD) to Paxalisib for Glioblastoma-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
US FDA Awards Fast Track Designation (FTD) to Paxalisib for Glioblastoma-PR Newswire APAC

SYDNEY, Aug. 20, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Kazia's paxalisib (formerly GDC-0084) for the treatment of glioblastoma,...

Read more: US FDA Awards Fast Track Designation (FTD) to Paxalisib for Glioblastoma-PR Newswire APAC

Business News

Top 5 Features To Look For When Shopping For Reliable Large Format Printers

For large-format printing, getting the right printer is important, especially in delivering the intended results in different ways for a business. Whether it is banners, posters, technical prints ...

Daily Bulletin - avatar Daily Bulletin

The Impact of a Defence Lawyer in Sydney: Providing Expert Legal Representation & Protection of Your Rights

In Sydney, as in other major cities, the role of a defence lawyer is pivotal within the legal system. Defence lawyers are tasked with defending individuals and organisations accused of criminal acti...

Daily Bulletin - avatar Daily Bulletin

Starting Your Own Design Agency

Starting a design agency can be both a thrilling and challenging journey. While your creative skills may be second nature—whether that’s in graphic design, branding, web design, or UX/UI—the busines...

Daily Bulletin - avatar Daily Bulletin